IGF2BP2 and pancreatic neoplasm: UDP‐GlcNAc:betaGal beta‐1,3‐N‐acetylglucosaminyltransferase 6 (B3GNT6) mRNA is modified with m6A, which is stabilized by IGF2BP2 binding and contributes to pancreatic cancer progression [34].